US bill to boost trial participation in rare diseases awaits president's nod
This article was originally published in SRA
Executive Summary
The US House of Representatives has cleared legislation that allows patients with rare diseases to participate in clinical trials without losing their eligibility to claim public healthcare benefits1. The Improving Access to Clinical Trials Act, which was cleared by the Senate earlier this year2, has now been forwarded to President Barack Obama, who is expected to sign it into law.